Advancing AI-driven technologies for Aging and AD/ADRD

AI and emerging technologies can help Americans live longer, healthier lives. AITC provides a national framework and dedicated infrastructure designed to move promising innovations from research to real-world impact.

View Awardees

Our partners

The organization is comprised of 5 AITC collaboratories and one coordinating center, AITC3.

JH AITCJohns Hopkins UniversityValidated tools for healthy aging and AD/ADRD.
MassAITCUniversity of Massachusetts AmherstConnected care and in-home sensing for aging in place.
Duke AITC-AIGEDuke UniversityGovernance and evaluation across the AI lifecycle.

AITC3Yale University
Indiana UniversityCoordinating Center

Stanford AITCStanford University & VA Palo AltoRight intervention, right person, right moment.
APEX-ADRDUniversity of California, Los AngelesCompressing AI evaluation from years to months.

The AITC program
at a glance.

Fueling breakthrough ideas
for healthier tomorrows.

Formerly the a2 Collective, the AITC program has funded 166 AI-driven AgeTech projects with more than $40M (opens in a new tab) to improve care and health outcomes for older adults, including persons with Alzheimer’s disease and related dementias (AD/ADRD).

Pilot awardees may receive access to study sites, datasets, and resources at each AITC, as well as mentorship from industry and university experts, major health systems, and venture capitalists, and are eligible to apply for $10K in AWS credits. Pilot awardees may also become more competitive for SBIR/STTR grant funding.

166AI-driven AgeTech projects

$40M+In program funding to date

$10KAWS credits per pilot awardee

Advancing AI-driven technologies for Aging and AD/ADRD

Our partners

The AITC programat a glance.

The AITC program
at a glance.